[AVDL] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[AVDL] Avadel Pharmaceuticals plc
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -12.15%
YoY- -16.50%
Quarter Report
AVDL's Result
AVDL's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 19,453 7,014 1,496 0 0 0 0 -
PBT -28,886 -36,185 -64,342 -31,364 -27,365 -20,076 -33,251 -8.93%
Tax -100 89 90 -580 85 70 30,193 -
NP -28,786 -36,274 -64,432 -30,784 -27,450 -20,146 -63,444 -40.86%
Tax Rate - - - - - - - -
Total Cost 48,239 43,288 65,928 30,784 27,450 20,146 63,444 -16.65%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -147.98 -517.17 -4,306.95 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.30 -0.41 -0.83 -0.48 -0.43 -0.33 -1.07 -57.06%
EPS Diluted -0.30 -0.41 -0.83 -0.48 -0.43 -0.33 -1.07 -57.06%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.